Oliver Dolan

CEO

Insider activity · 24 months0 buys3 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 3 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (4 ops.)

€85k

Latest filing published 14 Sept 2026 for Korro Bio, Inc., €59. Read the official filing

Filing timeline

BuySale

Oliver Dolan

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Oliver Dolan: trading record in brief

All filings by Oliver Dolan on record concern Korro Bio, Inc. In total, 6 filings cover trades dated from 15 December 2025 to 11 September 2026.

On the market, this insider has only sold: 4 sales, €85k in total. The amount is not disclosed for 1 filing. The rest of the record consists of 2 share grants. 2026 to date brings no purchases and 4 sales.

On 14 September 2026 came the latest disclosure, an open-market sale for €59 in Korro Bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.